Clinical Evaluation and Assesment of Ginigivitis Patients Treated by Yarrow Natural Extract in Compare to a Contro Group

Clinical Assessment of Antibacterial Anti-inflammatory Activities of Yarrow Moringa Herbal Combinations in Bucco Adhesive Films

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06070571

Enrollment

Registered

2023-10-06

Start date

2022-05-20

Completion date

2023-05-20

Last updated

2023-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Brief summary

A double-blind, prospective, randomized, intra-individual comparative, single-center clinical study was conducted. Participants were placed in parallel groups, and the study was performed in the Department of Operative Dentistry and Periodontology, Dental School and Hospital, Minia university to compare the antibacterial activity of yarrow Moringa herbal combinations nanoparticles in compared to Chlorhexidine as a potential treatment for gingivitis.

Interventions

DRUGYarrow and moringa mixture

yarrow and moringa mixture nano particles loaded on buccal film

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

25 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* a minimum of four natural uncrowned teeth in one quadrant present * good general health * can follow instructions

Exclusion criteria

* were pregnant or breastfeeding * evidence of antibiotic use during the 4 weeks prior to the study * were allergic to personal care/consumer products or their ingredients

Design outcomes

Primary

Measure	Time frame	Description
antibacterial and anti inflammatory activities	two weeks	scoring of erthymia and pain (no pain=0) and the other end (worst pain=10).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026